Trials / Completed
CompletedNCT02156427
Evaluation of Non-cultured Epidermal Cellular Grafting vs Hyaluronic Acid for Repigmenting Vitiligo and Piebaldism
A Multicenter Double-blind Placebo-controlled Trial of Non-cultured Epidermal Cellular Grafting Versus Hyaluronic Acid for Repigmenting Stable Leukoderma (Vitiligo and Piebaldism)
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 38 (actual)
- Sponsor
- Laboratoires Genévrier · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy of autologous epidermal cells suspension grafting using a newly developed device named VITICELL® compared to placebo. The secondary objective is to evaluate safety of VITICELL® and global satisfaction of patient and investigator.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | VITICELL | graft of autologus cells (kaeratonicytes and melanocytes) obtained after trypsinization of thin skin biopsy resuspended into hyaluronic acid |
| DEVICE | PLACEBO | hyaluronic acid alone |
Timeline
- Start date
- 2014-04-29
- Primary completion
- 2018-04-10
- Completion
- 2018-04-10
- First posted
- 2014-06-05
- Last updated
- 2019-10-14
Locations
5 sites across 3 countries: Belgium, France, Italy
Source: ClinicalTrials.gov record NCT02156427. Inclusion in this directory is not an endorsement.